1.
Clin Case Rep
; 7(4): 665-667, 2019 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30997059
RESUMO
In our case, the use of a low intravenous bolus dose of rFVIIa (recombinant factor VII activated; 15-20 mcg/kg) was effective and uneventful in controlling late postprocedural PDT bleeding associated with thrombocytopenia that cannot be corrected and after all other treatments failed.